Insider · CIK 0001891978
Alison D. Silva
Files at JUNS (JUPITER NEUROSCIENCES, INC.). First filing Jul 1, 2025, latest Jul 3, 2025.
Alison D. Silva files SEC Form 4 as director, COO and president at JUNS (JUPITER NEUROSCIENCES, INC.). Since Jul 1, 2025, Alison D. Silva has reported 2 open-market buys worth $2,627 and 0 open-market sells worth $0, the latest filed on Jul 3, 2025.
A track record needs three past buys with six months of prices behind them; Alison D. Silva has 0, so none is measured yet.
The newest scored trade: bought $772 of JUNS on Jul 1, 2025, filed Jul 3, 2025, scored 23 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JUNS: JUPITER NEUROSCIENCES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | JUPITER NEUROSCIENCES, INC. | $772 750 shares | +1% | - | |
| 23Weak | JUPITER NEUROSCIENCES, INC. | $1,855 1,800 shares | +2% | - |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | JUNS JUPITER NEUROSCIENCES, INC. | AGrant or award Stock Optionderivative | +1,027,304 | $0.00 | $0 | 1,027,304 | Jun 4, 2026 |
| Jul 2, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +255,320 | - | - | 255,320 | Jul 7, 2025 |
| Jul 1, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.03 | $257 | 112,277 | Jul 3, 2025 |
| Jul 1, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.03 | $257 | 112,527 | Jul 3, 2025 |
| Jul 1, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.03 | $259 | 112,777 | Jul 3, 2025 |
| Jun 2, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | MOption exercise Common Stock | +110,227 | $0.00 | $0 | 110,227 | Jul 1, 2025 |
| Jun 27, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.00 | $250 | 110,477 | Jul 1, 2025 |
| Jun 27, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +100 | $1.04 | $104 | 110,577 | Jul 1, 2025 |
| Jun 27, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.04 | $261 | 110,827 | Jul 1, 2025 |
| Jun 27, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.05 | $263 | 111,077 | Jul 1, 2025 |
| Jun 30, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +100 | $1.02 | $102 | 111,177 | Jul 1, 2025 |
| Jun 30, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.02 | $255 | 111 | Jul 1, 2025 |
| Jun 30, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.03 | $258 | 111,677 | Jul 1, 2025 |
| Jun 30, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +250 | $1.04 | $259 | 111,927 | Jul 1, 2025 |
| Jun 30, 2025 | JUNS JUPITER NEUROSCIENCES, INC. | POpen-market purchase Common Stock | +100 | $1.05 | $105 | 112,027 | Jul 1, 2025 |
Questions about Alison D. Silva
Answered from the filings on this page, as of the latest one.
Is Alison D. Silva buying or selling?
Not in the last 12 months. Alison D. Silva's latest open-market trade on SEC Form 4 was bought $772 of JUNS on Jul 1, 2025.
How did Alison D. Silva's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alison D. Silva has 0.
Where does Alison D. Silva file Form 4?
Alison D. Silva has filed Form 4 at JUNS (JUPITER NEUROSCIENCES, INC.) as President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.